Inventor
PERNER RICHARD J
US22 patents
⚠️ This page may combine multiple inventors who share the name “PERNER RICHARD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
12 patentsUS6933311B2Aug 23, 2005
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ABBOTT LAB24 citations92
US4963568AOct 16, 1990
Dopamine agonists
ABBOTT LAB52 citations90
US7998993B2Aug 16, 2011
TRPV1 antagonists
ABBOTT LAB8 citations83
US7902236B2Mar 8, 2011
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
ABBOTT LAB7 citations83
US7504520B2Mar 17, 2009
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
ABBOTT LAB7 citations73
US7335678B2Feb 26, 2008
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
ABBOTT LAB8 citations73
US7074805B2Jul 11, 2006
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ABBOTT LAB10 citations73
US6030969AFeb 29, 2000
5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
ABBOTT LAB14 citations73
US5591884AJan 7, 1997
Dopamine agonists
ABBOTT LAB10 citations73
US6831193B2Dec 14, 2004
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
ABBOTT LAB8 citations72
US8044069B2Oct 25, 2011
Compounds as calcium channel blockers
ABBOTT LAB6 citations62
US7767705B2Aug 3, 2010
Compounds that inhibit TRPV1 and uses thereof
ABBOTT LAB3 citations62
ABBVIE INC
3 patentsUS8648074B2Feb 11, 2014
Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers
ABBVIE INC6 citations72
US9751850B2Sep 5, 2017
TRPA1 antagonists
ABBVIE INC0 citations51
US8669255B2Mar 11, 2014
Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
ABBVIE INC0 citations41